97 related articles for article (PubMed ID: 16508156)
1. Formulation and evaluation of ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate.
Kakubari I; Shinkai N; Kawakami J; Uruno A; Takayasu T; Yamauchi H; Takayama S; Takayama K
Biol Pharm Bull; 2006 Mar; 29(3):513-6. PubMed ID: 16508156
[TBL] [Abstract][Full Text] [Related]
2. Effects of solvents on skin permeation of formoterol fumarate.
Kakubari I; Nakamura N; Takayasu T; Yamauchi H; Takayama S; Takayama K
Biol Pharm Bull; 2006 Jan; 29(1):146-9. PubMed ID: 16394528
[TBL] [Abstract][Full Text] [Related]
3. Effects of ethylcellulose and 2-octyldodecanol additives on skin permeation and irritation with ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate.
Kakubari I; Sasaki H; Takayasu T; Yamauchi H; Takayama S; Takayama K
Biol Pharm Bull; 2006 Aug; 29(8):1717-22. PubMed ID: 16880631
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
5. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
Shin SC; Choi JS
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
[TBL] [Abstract][Full Text] [Related]
6. Development and biopharmaceutical evaluation of quinupramine-EVA matrix containing penetration enhancer for the enhanced transdermal absorption in rats.
Shin SC; Kim J; Kim WJ; Kim SJ; Cho CW
Pharm Dev Technol; 2007; 12(5):429-36. PubMed ID: 17963142
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
Krishnaiah YS; Bhaskar P; Satyanarayana V
Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
[TBL] [Abstract][Full Text] [Related]
8. Studies on the transdermal delivery of nimodipine from a menthol-based TTS in human volunteers.
Krishnaiah YS; Bhaskar P
Curr Drug Deliv; 2004 Apr; 1(2):93-102. PubMed ID: 16305374
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of tolterodine by O-acylmenthol: In vitro/in vivo correlation.
Zhao L; Li Y; Fang L; He Z; Liu X; Wang L; Xu Y; Ren C
Int J Pharm; 2009 Jun; 374(1-2):73-81. PubMed ID: 19446762
[TBL] [Abstract][Full Text] [Related]
10. Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone.
Fujii M; Bouno M; Fujita S; Yoshida M; Watanabe Y; Matsumoto M
Biol Pharm Bull; 2000 Nov; 23(11):1341-5. PubMed ID: 11085363
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
Yang Z; Teng Y; Wang H; Hou H
Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of an extrafine fixed pMDI combination of beclometasone dipropionate/formoterol fumarate in adolescent asthma.
Kuna P; Govoni M; Lucci G; Scuri M; Acerbi D; Stelmach I
Br J Clin Pharmacol; 2015 Sep; 80(3):569-80. PubMed ID: 25808292
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability of two hydrofluoroalkane formulations of formoterol fumarate both delivered by pressurised metered dose inhaler.
Po CJ; Chandran SS; Syed N; Naidu KR; Rathod M; Sule A; Lulla A; Purandare S
Arzneimittelforschung; 2010; 60(2):81-6. PubMed ID: 20329656
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
Chambers F; Ludzik A
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
[TBL] [Abstract][Full Text] [Related]
16. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
[TBL] [Abstract][Full Text] [Related]
17. Effect of carvone on the permeation of nimodipine from a membrane-moderated transdermal therapeutic system.
Krishnaiah YS; Bhaskar P; Satyanarayana V
Pharmazie; 2003 Aug; 58(8):559-63. PubMed ID: 12967033
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
Tallury P; Alimohammadi N; Kalachandra S
Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
[TBL] [Abstract][Full Text] [Related]
19. Effect of ion-pairing and enhancers on scutellarin skin permeability.
Wang M; Fang L; Ren C; Li T
J Pharm Pharmacol; 2008 Apr; 60(4):429-35. PubMed ID: 18380914
[TBL] [Abstract][Full Text] [Related]
20. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
